The Division of Genomic Diagnostics and Bioinformatics has selected GenomOncology's Pathology Workbench and GenomAnalytics to help scale their molecular pathology lab's test volume and analysis, according to a press release on Thursday, September 29, 2020.
The division, led by director Alexander "Craig" Mackinnon, Jr., MD, PhD, intends to expand testing within the lab, as well as reduce the turnaround time from NGS sample to report by over 80%. Dr. Mackinnon's strategy is to impact patient care by dramatically improving the analytical capabilities of the lab.
GenomOncology's Pathology Workbench will help UAB scale their test volume due to the simplified workflow for variant analysis and comprehensive support for panels. In addition, the streamlined workflow will allow pathologists to return final reports to oncologists with reduced turnaround time. UAB is also using GenomAnalytics' cohort analysis capabilities to combine genomic and molecular data into one, comprehensive view. UAB will leverage the data visualization capabilities of GenomAnalytics for treatment and outcome analysis.
"The collaboration with the GenomOncology team and the overall flexibility of GenomOncology's solutions enables integration with the workflows of the UAB lab. This integration streamlines the variant review and analysis process, improving the turnaround time from NGS sample to report," said Craig Mackinnon, MD, PhD, Director of Genomics Diagnostics and Bioinformatics at UAB.